|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:1329-1335
© 2007 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
Childrens Hospital, Boston, Harvard Medical School, Boston, Mass.
Poster Presentation at the Western Thoracic Surgical Association meeting, Sun Valley Idaho, June 21-24, 2006.
Received for publication June 19, 2006; revisions received November 10, 2006; accepted for publication December 26, 2006. * Address for reprints: Frank A. Pigula, MD, Department of Cardiac Surgery, Childrens Hospital, 300, Longwood Ave, Boston, MA 02115. (Email: frank.pigula{at}childrens.harvard.edu).
| Abstract |
|---|
|
|
|---|
Methods: A retrospective case review of all cases of conotruncal anomalies at Childrens Hospital Boston revealed 16 patients with hemitruncus. Ten patients had surgery in the neonatal period (<30 days), 4 at 1 to 6 months, 1 at 8 months, and 1 at 2 years. Diagnosis of hemitruncus was the indication for operation in all but 1. Fourteen of the 16 had anomalous right pulmonary artery from aorta, and 2 had left pulmonary artery from aorta. Common associated anomalies included patent foramen ovale in 14, patent ductus arteriosus in 11, and ventricular septal defect in 4. All patients had elevated right ventricular pressures with systemic pressures in 5 and suprasystemic pressures in 9.
Results: There was 1 operative death in this series in an infant who died from sepsis following ligation of a tracheoesophageal fistula. One patient required reoperation for supravalvar aortic stenosis and right pulmonary artery stenosis 1 year postoperatively. Three patients required 4 catheter-based interventions postoperatively. At 20 years, survival by Kaplan–Meier was 93%; freedom from reoperation, 93%; and freedom from catheter reintervention, 79%.
Conclusions: Early repair of hemitruncus results in excellent hemodynamic and anatomic results. Survival is excellent, with a low incidence of reoperation or reintervention.
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
All patients preoperative studies, including echocardiograms and cardiac catheterization data, were reviewed. Data obtained from the preoperative echocardiograms included: the site of origin of the anomalous pulmonary artery, presence of additional intracardiac defects, right ventricular pressures, and presence or absence of right ventricular dysfunction.
Clinical charts and databases were reviewed. Intraoperative variables of interest included: survival, procedure performed, cardiopulmonary bypass times, aortic crossclamp times, and circulatory arrest times. Postoperative variables of interest were: length of intensive care unit stay, length of hospital stay, duration of ventilatory support, surgical and catheter reinterventions, surgical complications, and length of follow-up.
Results are reported as means ± SD. Probabilities of survival, freedom from reoperation, and freedom from catheter reinterventions were estimated using the Kaplan–Meier method. Intercooled Stata version 8.1 (Stata Corporation, College Station, Tex) was used for statistical analysis.
| Results |
|---|
|
|
|---|
All patients had preoperative echocardiograms. Five patients also underwent cardiac catheterization. In 3 patients the diagnosis was missed on preoperative echocardiogram. In 2 of these 3 patients, the diagnosis was established on routine preoperative cardiac catheterization early in the series, and both had anomalous right pulmonary artery (RPA) arising from the aorta. More recently, in 1 patient the diagnosis was missed on preoperative transthoracic echocardiogram. This patient was taken to the operating room for symptoms of severe congestive heart failure attributed to 2 muscular ventricular septal defects (VSDs). The diagnosis was made when intraoperative transesophageal echocardiography could not clearly visualize the origin of the left pulmonary artery (LPA). Fourteen patients had a right anomalous pulmonary artery arising from the aorta. In 7 patients the RPA arose directly posterior from the ascending aorta, 5 had the RPA arising posterior but leftward, 1 had the RPA arising posterior and rightward, and 1 patient had the RPA arising from anterior rightward aspect of ascending aorta. Two patients had an anomalous left pulmonary artery arising from the aorta. Both arose from an anterior and leftward aspect of ascending aorta and shared a common but intact wall with the main pulmonary artery (MPA). Additional defects and surgical details are outlined in Table 1. After excision of the anomalous pulmonary artery with a rim of aortic tissue, 11 of the 16 patients had primary closure of aorta, and a pericardial patch was used to close the aortic defect in 5 patients. Thirteen patients had direct implantation of anomalous pulmonary artery onto the side of MPA; 3 patients had anterior pericardial patch augmentation of this anastomosis to maintain a tension-free anastomosis. All procedures were done under cardiopulmonary bypass. One of the 16 patients had repair performed on beating heart with no crossclamp. Seven patients had a period of circulatory arrest, all before 1991. Only 2 of these patients had an additional VSD or arch augmentation. The mean cardiopulmonary bypass time was 95 ± 37.4 minutes (range of 65-201 minutes), the mean aortic crossclamp time was 42 ± 18.8 minutes (range of 22-80 minutes), and the mean circulatory arrest time was 45 ± 15.7 minutes (range of 29-76 minutes). The mean time to extubation was 2.5 ± 1.3 (range of 1-5 days), mean length of stay in intensive care unit was 3.8 ± 1.4 days (range of 3-7 days), and mean length of hospital stay was 9 ± 2.8 days (range of 5-17 days).
|
One other patient developed postoperative seizure (patient number 5).
One of 16 patients (6%) required reoperation for RPA occlusion and ascending aortic stenosis at 1 year after initial surgery. At initial operation, this patient had primary closure of aorta and pericardial augmentation of anterior aspect of RPA/MPA anastomosis. She then required a second bypass to augment the anterior RPA from MPA to hilum. During reoperation, the patient had interposition of an 11-mm homograft conduit between proximal MPA and distal RPA and ascending aortic enlargement with a Hemashield patch (Boston Scientific, Natick, MA). The patient also required subsequent catheter intervention for RPA dilatation and stenting.
There were 4 catheter-based interventions on 3 of 16 patients (18%). Two of the 3 patients had pulmonary artery dilatation and stenting. One patient had balloon dilatation of the pulmonary artery. Two of these 3 patients had pericardial augmentation of the RPA to MPA anastomosis anteriorly.
Probability of freedom from death at 20 years by Kaplan–Meier estimate was 93%, freedom from reoperation at 20 years was 93%, and freedom from catheter reintervention at 20 years was 79% (Figure 1).
|
| Discussion |
|---|
|
|
|---|
Embryologically pleuripotent neural crest cells play a role in the development of the conotruncus and ascending aorta. Origin of the left or right pulmonary artery from the aorta is the result of embyologically distinct, but related, processes. Failure of fusion of the LPA to MPA, due to the absence of the left sixth arch, results in persistence of an aortic sac from which the LPA arises.5
Anomalous origin of RPA from aorta results from a delay in or abnormal migration of the sixth right aortic arch to the left side.6-8
This entity is 4 to 8 times more common than anomalous origin of LPA from aorta.9
Anomalous origin of LPA, when it does occur, is often associated with right aortic arch. In our series, 14 of the 16 patients (87.5%) had RPA as the anomalous pulmonary artery. DiGeorge syndrome is less common with hemitruncus anomalies as compared with other conotruncal malformations such as truncus arteriosus or interrupted aortic arch.10
In our case series we had only 2 patients (12%) with thymic hypoplasia.
Associated anomalies include PDA, VSD, tetralogy of Fallot, interrupted aortic arch, aortopulmonary window, and isthmic hypoplasia.9-11
In our series we had only 1 patient with conoventricular VSD and PS and 1 patient with arch hypoplasia. There were no cases of interrupted aortic arch or aortopulmonary window. We had 8 patients with isolated hemitruncal lesions with no other major intracardiac or arch anomalies except for a PDA or PFO.
The pathophysiology resulting from this lesion exposes the pulmonary circulation of both lungs to pressure and volume overload. In the absence of intracardiac shunting, the entire cardiac output flows to the single lung attached to the right ventricle while the "hemitruncus" lung is exposed to unrestricted aortic blood flow and pressure. If this abnormal circulation is allowed to continue uncorrected, the early development of PVOD can be expected.12-14
In our series, 5 patients had diagnostic catheterization postoperatively. All 5 patients had systemic or suprasystemic right ventricular pressures preoperatively. Postoperatively, 3 of these patients had normalization of their right ventricular and pulmonary arterial pressures and trivial or no gradient across their anastomosis. One patient had elevated right ventricular and pulmonary arterial pressures that gradually improved with time and no gradient across anastomosis. The fifth patient had differential pulmonary vascular resistance and remained elevated on the side of the repair. Anastomotic adequacy was assured by catheterization. The child is well, and follow-up catheterization is planned.
Clinically these patients often present early in life with progressive respiratory distress and evidence of congestive heart failure. There is often a degree of cyanosis from right-to-left shunting through the PFO or PDA, secondary to elevated end diastolic pressures in a hypertensive, noncompliant right ventricle or from increased pulmonary resistance. The right ventricular pressures are elevated and may be systemic or suprasystemic.6,13,14
In our series, 14 patients had systemic or suprasystemic right ventricular pressures, and the remaining 2 patients had half systemic right ventricular pressures. Diagnosis is usually established by echocardiography, but imaging of the branch pulmonary arteries may be difficult, and cardiac catheterization is indicated when clinical failure seems out of proportion to the cardiac anatomy. More recently computed tomography angiograms and magnetic resonance imaging are being used for confirmation of suspected cases, especially in adults and older children.15,16
Early repair is the therapy of choice. Early repair avoids persistent pulmonary hypertension and the development of pulmonary vascular occlusive disease. Direct implantation was introduced by Kirkpatrick and colleagues17
in 1967 and Stanton and associates18
in 1968. Several techniques have been described in cases where direct implantation is not feasible due to length discrepancy. Van Son and Hanley19
in 1996 described anterior MPA flap anastomosis to a posterior aortic/branch pulmonary arterial flap. Prifty and colleagues20
in 2002 described a double surgical flap technique using a ring of aorta divided with one-third posterior flap and two-thirds anterior flap. The posterior flap was anastomosed to a posteriorly based trapdoor flap of MPA folded back on itself. The anterior two thirds of aortic flap were then anastomosed anteriorly to the edge of the MPA trapdoor. The entire anastomosis was performed anterior to the aorta. Other modifications of aortic/pulmonary arterial flap techniques have been described.21-23
In our series, we were successful in direct implantation of anomalous pulmonary artery into MPA in 13 of 16 patients. Only 3 patients required fixed autologous pericardial patch augmentation of the pulmonary artery implant site. Two of these 3 patients had the anomalous pulmonary artery arising from the anterolateral aspect of the aorta (RPA from right anterolateral aspect in 1 and LPA from left anterolateral aspect in the second), and therefore a greater length had to be traversed for anastomosis. One of these 2 required intervention for dilatation and stenting of the implanted pulmonary artery. The third patient developed complete occlusion of RPA requiring reoperation and homograft conduit interposition of the RPA. This homograft required later dilatation and stenting.
Hospital mortality has been reported as anywhere from 0% to 21%24-28
and the need for reintervention, 12.5% to 36%.24
Postoperative follow-up requires echocardiography and nuclear scintigraphy to diagnose acquired peripheral pulmonary stenosis.29
Catheterization can be performed as needed when indicated by these noninvasive studies. In our series, there was 1 operative death (6%), and 3 patients required catheter-based intervention (19%). One patient required operative intervention (6%).
In summary, the early diagnosis and prompt surgical treatment of hemitruncus results in excellent survival and avoids development of pulmonary vascular obstructive disease. Although the frequency of reintervention is low, it is usually directed at the pulmonary artery/MPA implantation site, and a variety of techniques to complete this anastomosis have been developed. When possible, we prefer techniques that use autologous tissue in the pulmonary artery anastomosis.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |